FLNA Filana Therapeutics, Inc.
Healthcare$1.31+1.55%ClosedMarket Cap: $63.3M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.93
P/S
0.00
EV/EBITDA
0.29
DCF Value
$1.85
FCF Yield
-141.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-99.8%
ROA
-71.9%
ROIC
-120.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-11.2M | $-10.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-13.6M | $-12.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-95.4M | $-91.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-11.9M | $-10.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-45.4M | $-44.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-24.6M | $-23.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-29.5M | $-27.6M | $— | — |
| FY null | $0.00 | NaN% | $-141.4M | $-24.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-30.6M | $-27.9M | $— | — |
| FY null | $0.00 | NaN% | $-106.0M | $-97.2M | $— | — |
| FY null | $0.00 | NaN% | $-80.0M | $-76.2M | $— | — |
| FY 2021 | $0.00 | NaN% | $-32.9M | $-32.4M | $-0.82 | — |